Kenneth Duncan Email and Phone Number
Kenneth Duncan work email
- Valid
Kenneth Duncan personal email
- Valid
- Valid
Kenneth Duncan phone numbers
Experienced enterprise and scientific leader with a track record of building strong, effective teams able to deliver both first-in-class and best-in-class programs into the clinic. Through my career I have been fortunate to make contributions to nine clinical candidates, so far resulting in one approval.
Accent Therapeutics, Inc.
View- Website:
- accenttx.com
- Employees:
- 33
-
Vice President, ChemistryAccent Therapeutics, Inc.United States
-
Sr. Vice President, ChemistryAccent Therapeutics, Inc. Jan 2024 - PresentLexington, Massachusetts, Us
-
Vice President, ChemistryAccent Therapeutics, Inc. Jan 2020 - Jan 2024Lexington, Massachusetts, Us
-
Vp, Head Of Medicinal ChemistryEpizyme Aug 2019 - Jan 2020
-
Executive Director, Head Of Medicinal ChemistryEpizyme Nov 2017 - Aug 2019
-
Director, Head Of Medicinal ChemistryEpizyme Apr 2017 - Nov 2017
-
Associate Director, Molecular DiscoveryEpizyme Sep 2013 - Apr 2017Project leader for PRMT5 program delivering the first orally available RMT inhibitor molecule. Co-leader of successful joint research alliance on multiple novel targets with pharmaceutical partner.
-
Principal Scientist, Molecular DiscoveryEpizyme Jan 2011 - Sep 2013
-
Manager, Discovery ChemistryAntisoma Jun 2008 - Dec 2010London, GbManaged pre-clinical discovery and development of novel kinase inhibitor platform for autoimmune disease targets. Program lead from inception through to pre-IND stage delivering multiple candidates. Worked extensively with CROs, academic partners and colleagues designing screening cascades, development pathways and animal models. -
Senior ScientistXanthus Pharmaceuticals (Acquired By Antisoma) Nov 2006 - May 2008
-
Research ChemistInfinity Pharmaceuticals Inc. Jun 2006 - Nov 2006Cambridge, Massachusetts, UsWorked in Diversity Orientied Synthesis (DOS) team developing 15,000 member library based on a natural product core. -
Research ScientistCyclacel Pharmaceuticals, Inc. Nov 2001 - Dec 2005Senior chemist on number of drug discovery projects in kinase and protien-protien interaction targets. Kinase oncology candidate now being evaluated in the clinic. Lead chemist in diabetes program which passed in-vivo proof of efficacy. 8 Patent applicationsfrom work at Cyclacel.
-
Associate ScientistSolvay Interox Mar 1996 - May 1997Developed novel bleaching agent for detergents business and transferred technology from bench to pilot plant.
Kenneth Duncan Skills
Kenneth Duncan Education Details
-
University Of StrathclydeChemistry -
University Of StrathclydeChemistry
Frequently Asked Questions about Kenneth Duncan
What company does Kenneth Duncan work for?
Kenneth Duncan works for Accent Therapeutics, Inc.
What is Kenneth Duncan's role at the current company?
Kenneth Duncan's current role is Vice President, Chemistry.
What is Kenneth Duncan's email address?
Kenneth Duncan's email address is ke****@****ail.com
What is Kenneth Duncan's direct phone number?
Kenneth Duncan's direct phone number is +157376*****
What schools did Kenneth Duncan attend?
Kenneth Duncan attended University Of Strathclyde, University Of Strathclyde.
What skills is Kenneth Duncan known for?
Kenneth Duncan has skills like Drug Discovery, Chemistry, Oncology, Drug Development, Clinical Development, Cro, Medicinal Chemistry, Technology Transfer, Organic Chemistry, Molecular Modeling, In Vivo, Program Management.
Who are Kenneth Duncan's colleagues?
Kenneth Duncan's colleagues are David Brennan, Taylor Hotz, Kevin Mcgann, Shihua Yao, Gordon J Lockbaum.
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial